Enrica Morra - Concepedia

Author

Enrica Morra

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

Also Known As

E Morra, E. MORRA, E. Morra, Enrica Morra, Morra,Enrica

365

Publications

15.8K

Citations

H-Index

133

Concepts

All Affiliations

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda Istituti di Ricovero e Cura a Carattere Scientifico University of Pavia Policlinico San Matteo Fondazione University of Milan

About

Enrica Morra is an author at Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda specializing in medicine, pathology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	89	3.6K
2	Health Sciences	20	27	1.1K
3	Cell Biology	11	12	702
4	Allergy	3	3	127
5	Biostatistics	2	2	158

Enrica Morra

159

Publications

13.3K

Citations

H-Index

Page 1

	Year	Citations
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia Francesco Lo‐Coco, Giuseppe Avvisati, Marco Vignetti, New England Journal of Medicine	2013	1.6K
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment Francisco Cervantes, Brigitte Dupriez, Arturo Pereira, Blood	2008	1.2K
A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment) Francesco Passamonti, Francisco Cervantes, Alessandro M. Vannucchi, Blood	2009	954
Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib Carlo Gambacorti‐Passerini, Laura Antolini, François‐Xavier Mahon, JNCI Journal of the National Cancer Institute	2011	424
MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction Lian Xu, Zachary R. Hunter, Guang Yang, Blood	2013	407
C-kit mutations in core binding factor leukemias Alessandro Beghini, Paolo Peterlongo, Carla B. Ripamonti, Blood	2000	299
Response assessment in <scp>W</scp>aldenström macroglobulinaemia: update from the <scp>VI</scp>th <scp>I</scp>nternational <scp>W</scp>orkshop Roger G. Owen, Robert A. Kyle, Marvin J. Stone, British Journal of Haematology	2012	264
Prognostic Factors for Malignant Transformation in Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma Clara Cesana, Catherine Klersy, Luciana Barbarano, Journal of Clinical Oncology	2002	239
Long-term outcomes of 107 patients with myelofibrosis receiving JAK1/JAK2 inhibitor ruxolitinib: survival advantage in comparison to matched historical controls Srđan Verstovšek, Hagop M. Kantarjian, Zeev Estrov, Blood	2012	214
Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients Giuseppe Visani, Carlo Finelli, U. Castelli, British Journal of Haematology	1990	193

Page 1